FDA Inspection 989472 — Carter BloodCare - Arlington
The FDA completed an inspection of Carter BloodCare - Arlington on September 15, 2016 in Arlington, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 15, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Arlington, TX (United States)